{
  "Variants Include": [
    {
      "Gene": "PARKIN",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.248G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "248"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": "83"
          },
          "Description in input context": "c.248G>A (p.G83D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0015379"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot (LC3 Immunoprecipitation/Immunofluorescence assay)",
      "Material used": {
        "Material Source": "Dopamine-deprived medium",
        "Material Name": "Mouse N201 Kun什N201 (dopaminergic neurons)",
        "Description": "The experiment was conducted using mouse dopamine-deprived medium derived from N201 Kun什N201 (dopaminergic neurons)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.248G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of function",
          "Result Description": "Parkin C289G mutant exhibited 50% reduction in LC3 immunoprecipitation and mitochondrial LC3 accumulation compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Two biological replicates were performed with ±10% variability between them."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each condition was tested in triplicate to ensure reproducibility."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type Parkin immunoprecipitation was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-specific immunoprecipitation controls were included."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N/A"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N/A"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by post-hoc testing."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "LC3 immunoprecipitation and mitochondrial LC3 accumulation levels above 150% of the wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "LC3 immunoprecipitation and mitochondrial LC3 accumulation levels below 60% of the wild-type.",
        "Source": "Custom determination based on observed variability."
      },
      "Approved assay": {
        "Approved assay": "Parkin C289G mutant cell line"
      }
    }
  ]
}